As sgRNAs were unavailable for CD2, we alternatively knocked out CD58, the cognate ligand for CD2, in MDA-MB-231 breast cancer cells (Supplemental Figure 12F, right panel). This evidence concerns the gene CD58 and breast carcinoma.